Implementing personalized cancer care.

Area of Science:

• Oncology
• Genomics
• Pharmacology

Background:

• Personalized cancer care hinges on understanding cancer genomics, analytical methods, drug mechanisms, and data interpretation.
• A major hurdle in personalized oncology is accessing targeted therapies aligned with a patient's tumor genomic profile.

Approach:

• Propose a national facilitated access program and registry for off-label use of targeted anti-cancer drugs.
• This program would match patients with drugs based on tumor genomic profiles and guide physicians in interpreting genomic tests.
• It would also provide pharmaceutical companies, payers, and regulators with real-world data on drug use, outcomes, and safety.

Key Points:

• Facilitates patient access to genomically matched targeted therapies.
• Supports physicians with genomic test interpretation and drug access.
• Generates crucial real-world data for industry stakeholders and regulatory bodies.

Conclusions:

• This initiative can enable personalized medicine delivery while gathering valuable data for future clinical care and research.
• Prospective trials are underway to validate the benefits of matching drugs to genomic alterations, but this program offers immediate facilitation.